Pharma Sector Seeks Drug Price Deregulation: Impact on Pharmaceutical Stocks
Pakistan's pharmaceutical sector is advocating for deregulation of drug prices, arguing that current government controls hinder profitability and investment. This move, if successful, could significantly alter the earnings landscape for listed pharma companies.